| 时间 | 融资买入 万元 |
融资余额 亿元 |
融券余量 万股 |
| 2026-09-29 | 809.95 | 5.63 | 5.89 |
| 2026-09-28 | 1283.97 | 5.7 | 5.16 |
| 2026-09-24 | 1259.95 | 5.77 | 5.55 |
| 2026-09-23 | 1255.67 | 5.81 | 5.99 |
| 2026-09-22 | 3376.28 | 5.89 | 5.94 |
| 2026-09-21 | 3075.59 | 5.88 | 5.95 |
| 2026-09-18 | 1334.69 | 5.8 | 5.68 |
| 2026-09-17 | 1163.4 | 5.8 | 5.87 |
| 2026-09-16 | 1160.23 | 5.79 | 6.09 |
| 2026-09-15 | 1746.42 | 5.83 | 6.18 |
| TBP 3Doctors (HK) Limited | 2671.74万股 2026-09-28 | 减持 12.97% |
| 张阳 | 2181.57万股 2026-09-28 | 未变 10.59% |
| TBP 3Doctors (HK) Limited | 2880.74万股 2026-09-03 | 减持 13.99% |
| 张阳 | 2181.57万股 2026-09-03 | 未变 10.59% |
| tbp 3doctors (hk) limited | 3019.04万股 2026-06-30 | 减持 14.66% |
| 张阳 | 2181.57万股 2026-06-30 | 未变 10.59% |
| 栾国明 | 859.24万股 2026-06-30 | 未变 4.17% |
| 于春江 | 859.24万股 2026-06-30 | 未变 4.17% |
| 石祥恩 | 604.08万股 2026-06-30 | 未变 2.93% |
| 中国银行-华宝中证医疗交易型开放式指数证券投资基金 | 482.72万股 2026-06-30 | 减持 2.34% |
| 华宝中证医疗ETF | 482.72万股 2026-06-30 | 增持 2.34% |
| 长城消费增值混合 | 60.09万股 2026-06-30 | 减持 0.29% |
| 长城消费增值混合C | 60.09万股 2026-06-30 | 减持 0.29% |
| 银河医药混合C | 51.92万股 2026-06-30 | 增持 0.25% |
| 银河医药混合 | 51.92万股 2026-06-30 | 增持 0.25% |
| 国泰中证医疗ETF | 41.58万股 2026-06-30 | 增持 0.2% |
| 易方达中证医疗ETF | 29.37万股 2026-06-30 | 增持 0.14% |
| 广发中证全指医药卫生ETF | 28.38万股 2026-06-30 | 新进 0.14% |
| 广发中证医疗ETF | 28.03万股 2026-06-30 | 增持 0.14% |
| 南方中证1000ETF | 15.74万股 2026-06-30 | 减持 0.08% |
| 时间 | 持股基金数 | 基金占流通股总比例 |
| 2026-06-30 | 142 | 5.41% |
| 2026-03-31 | 20 | 2.06% |
| 2025-12-31 | 82 | 6.83% |
| 2025-06-30 | 82 | 6.79% |
| 2024-12-31 | 61 | 2.19% |
 |
 |
三博脑科互动问答